Literature DB >> 8662790

cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases.

F R McKenzie1, J Pouysségur.   

Abstract

Growth factors stimulate fibroblast cell division by activating the recently identified mitogen-activated protein kinase (MAP kinase) signaling cascade. In contrast to our previous work (Kahan, K., Seuwen, K., Meloche, S. and Pouysségur, J. (1992) J. Biol. Chem. 267, 13369-13375), several reports have suggested that an elevation in intracellular cAMP blocks cell proliferation by attenuating MAP kinase activation. Hence we re-examined the effect of a long term increase in intracellular cAMP and therefore cAMP-dependent protein kinase (PKA) activation on the MAP kinase cascade in CCL39 fibroblasts. The concomitant addition of cAMP-elevating agents prostaglandin E, (PGE1) and IBMX did not inhibit the mitogen-mediated activation of p44 MAP kinase. However, a 5-min PGE1/IBMX pretreatment abolished the MAP kinase response, in a manner correlating with the extent of PKA activity. This inhibition was temporal in nature, and while modifying the time course of growth factor-mediated p44 MAP kinase, activation did not diminish the magnitude of the response. Thus the major peak of MAP kinase activity normally present 5 min after alpha-thrombin addition was now evident at 10 min in the presence of PGE1/IBMX. CCL39 cell proliferation is inhibited by elevated cAMP levels. Such an inhibition could reflect either a reduction in the number of cells entering the cell cycle or a delay in the time required to go through the cycle. Bromodeoxyuridine labeling experiments revealed that the cAMP-mediated inhibition of DNA synthesis in CCL39 cells was not due to a delay in S phase entry, but was due to a reduction in the number of cells entering S phase. Thus we conclude that although PKA activation may slightly modify the time course of MAP kinase activation in response to mitogens in CCL39 cells, the PKA-mediated inhibition of cell division occurs through modulation of an intracellular target, distinct from the p42/p44 MAP kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662790     DOI: 10.1074/jbc.271.23.13476

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells.

Authors:  G R Post; L R Collins; E D Kennedy; S A Moskowitz; A M Aragay; D Goldstein; J H Brown
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

2.  Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1.

Authors:  Steven K Huang; Scott H Wettlaufer; Jooho Chung; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-17       Impact factor: 6.914

3.  Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2.

Authors:  Beatriz Del Valle-Pérez; Vanesa Gabriela Martínez; Cristina Lacasa-Salavert; Agnès Figueras; Sandor S Shapiro; Toshiro Takafuta; Oriol Casanovas; Gabriel Capellà; Francesc Ventura; Francesc Viñals
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

4.  Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity.

Authors:  F Viñals; J Pouysségur
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms.

Authors:  Nicolas Dumaz; Yvonne Light; Richard Marais
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin.

Authors:  L R Chaudhary; L V Avioli
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

7.  Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.

Authors:  A Sachinidis; C Seul; I Gouni-Berthold; S Seewald; Y Ko; H Vetter; J Fingerle; J Hoppe
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals.

Authors:  Gray W Pearson; Svetlana Earnest; Melanie H Cobb
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes.

Authors:  T A Diggle; N T Redpath; K J Heesom; R M Denton
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  Selection of a WEHI-3B leukemia cell subclone resistant to inhibition by cholera toxin.

Authors:  Augusto Pessina; Attilia Giuliani; Cristina Croera; Paola Foti; Lucia Mascolo; Giuseppina Gagliardi; Maria Grazia Neri
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.